Delivery service
Free Worldwide Shipping & Returns
ASEPROMOL Solution for horses, dogs, cats 100ml (3.4 fl oz)
Сats, dogs, horses for premedication before surgery
Acepromazine maleate is a neuroleptic from the group of phenothiazines, sedatives. Its use as a solution for injection of 1% provides a calming and muscle relaxant effect by reducing the excitation of the central nervous system. At the same time, the drug has hypothermic, antihypertensive, antihistamine, adrenolytic, antispasmodic, antiemetic effect, enhances hypnotics and local anesthetics.
-
Zpril Solution for Cattle, Horse and more 100ml
Solution sulfamethazine + trimethoprim Zpril (Sulmet)
Sulfamethazine is a synthetic chemotherapeutic agent from the sulfamide group. Trimethoprim is a synthetic chemotherapeutic agent derived from diaminopyrimidine. Separately, each component has a bacteriostatic mechanism, but sulfamethazine and trimethoprim, taken in a 4: 1 ratio, enhance the effect of the drug and give it a bactericidal nature of action. Such synergy is manifested due to the fact that its components affect two sequential processes that are necessary for the synthesis of tetrahydrofolic acid or bacterial folic acid, which plays a major role in the synthesis of bacterial purines. The bacterial wall is impermeable to folates, so the synthesis of purines depends on the intrinsic synthesizing ability of microorganisms.
Zpril powder for Cattle, Horse and more
POWDER sulfamethazine + trimethoprim Zpril (Sulmet)
The combination of sulfamethazine-trimethoprim has a broad spectrum of action, covering gram-positive and gram-negative bacteria. The microorganisms that are very sensitive to the drug include the following bacteria: Escherichia coli, Clostridium spp., Shigella spp., Salmonella spp., Proteus mirabilis, Bacillus anthracis, Pasteurella spp., Haemophilus influenzae, Haemophilus ginar. Streptococcus pneumoniae, S. pyogenes, S. faecalis, S. viridans, S. agalactiae, Staphylococcus aureus, Proteus spp. and Brucella spp.Antibiotics & Pharmacy Livestock
The use of antibiotics in animal husbandry is the use of antibiotics for any purpose, in animal husbandry from livestock, which includes treatment in case of illness ( therapeutic ), treatment of a group of animals when at least one is diagnosed with a clinical infection (metaphylaxis), and preventive treatment ( prevention). Antibiotics are an important tool for treating animal and human diseases, protecting animal health and welfare, and ensuring food safety. However, if used irresponsibly, this can lead to antibiotic resistance, which can affect human, animal, and environmental health. Although levels of use vary greatly from country to country, for example, in some Northern European countries very low amounts are used to treat animals compared to humans, worldwide, it is estimated that 73% of antimicrobials (mainly antibiotics) are consumed by farm animals. In addition, a 2015 study also estimates that global use of agricultural antibiotics will increase by 67% from 2010 to 2030, mainly due to increased use in developing BRIC countries. This is a concern because antibiotic resistance is considered a serious threat to human and animal welfare in the future, and rising levels of antibiotics or antibiotic-resistant bacteria in the environment may lead to an increase in drug-resistant infections in both cases. Infectious diseases are the third leading cause of death in Europe, and a future without effective antibiotics will fundamentally change the methods of modern medicine and veterinary medicine. However, laws and other restrictions on the use of antibiotics in farm animals are currently being introduced around the world. In 2017, the world health organization strongly recommended reducing the use of antibiotics in animals used in the food industry. The use of antibiotics to promote growth has been banned in the European Union since 2006, and the use of sub-therapeutic doses of medically important antibiotics in animal feed and water to promote growth and improve feed efficiency has been illegal in the United States since January 1. In 2017, through a change in legislation passed by the food and drug administration (FDA), which sought voluntary consent from drug manufacturers to re-label their antibiotics.